What we need to know for the next generation of clinical trials for post-traumatic epilepsy.
May 3rd to May 6th 2026, The Nassau Inn, Princeton, New Jersey
Sunday, May 3rd beginning 6 PM
Welcome Reception
Monday, May 4th from 8:30 AM to 5 PM
View Day 1 Full Agenda and Speakers
Opening Remarks
Mechanism of PTE in Preclinical Studies
Post-Traumatic Epilepsy: The Lived Experience
Mechanisms of PTE in Pre-Clinical Studies Lessons from EpiBios4Rx
Discussion and Wrap-up of Day 1:
What are the most promising mechanisms to target for anti-epileptogenic therapies?
What are the most promising animal models?
Tuesday, May 5th from 8:30 AM to 5:00 PM
View Day 2 Full Agenda and Speakers
Epidemiology of PTE
Clinical risk factors for PTE
The importance of Common Data Elements for PTE research
Clinical risk factors for PTE
Discussion and Wrap-up of Day 2:
What are the ideal patient populations to recruit in early phase clinical trials of anti-epileptogenic therapies for PTE?
Conference Dinner - more details to follow
Wednesday, May 6th 8:30 AM to 12:15 PM
View Day 3 Full Agenda and Speakers
Promising Biomarkers for PTE
Promising Pharmacologic and Non-Pharmacologic Therapies for PTE
Discussion and Wrap-up:
How will we prioritize therapies for early Phase Clinical Trials?